how long to run igf-1 lr3 LONG® R³ IGF-I QK041 - Recombinant human/bovine/porcine IGF-1
Description
Roche) and DNase (1 l/ml
Steroids, diphenhydramine and bronchodilators can help resolve the anaphylactoid reactions and should be given so that NAC therapy can be continued under close monitoring
According to the phase 1 clinical data disclosed by Alnylam, 9 givosiran dosed at 2.5 mg/kg once-monthly significantly reduced the levels of ALAS1 mRNA, delta aminolevulinic acid (ALA) and porphobilinogen (PBG), with higher than 80% inhibition efficiency, which was accomplished with a 79% decrease in the mean annualized attack rate compared to that of the placebo
: ( )
M.Abdel-MagedA
